Study: Norouzzadeh 2025, Complementary Therapies in Medicine

Efficacy and safety of Hibiscus sabdariffa in cardiometabolic health: An overview of reviews and updated dose-response meta-analysis

Citation

Norouzzadeh M, Hasan Rashedi M, Azizi MH, Teymoori F et al (2025). Complementary Therapies in Medicine. PubMed id 39870328.

Open on PubMed

Cards that cite this study (1)

Each card gives its own wording for who was tested, how and what was found.

  • Hibiscus (sorrel, zobo, bissap) and blood pressure Tier A thin

    B 1,797 people across 26 randomised trials (Iran, Mexico, Egypt, Nigeria and others) (n=1797)

    Umbrella review of meta-analyses plus updated dose-response meta-analysis, graded with GRADE and credibility tools.

    Hibiscus lowered systolic and diastolic pressure compared with placebo and other teas, dose-dependently, with no significant difference from antihypertensive drugs. The authors rated the credibility of a fall of more than 10 mmHg as moderate. The authors note long-term and therapeutic-dose safety needs monitoring.

    As recorded in this card: Norouzzadeh M, Hasan Rashedi M, Azizi MH, Teymoori F et al (2025), Complementary Therapies in Medicine, [review]

This is information, not medical advice. If you are worried, see a doctor or pharmacist. How we grade the evidence. All studies.